Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic

Area of Science:

• Public Health
• Infectious Disease Prevention
• Health Policy

Background:

• The United States possesses the necessary tools to end the HIV epidemic.
• Progress in combating HIV has significantly slowed.
• A critical barrier is the underuse of pre-exposure prophylaxis (PrEP), a medication that can prevent HIV acquisition.

Purpose of the Study:

• To propose a novel financing and delivery system for pre-exposure prophylaxis (PrEP).
• To facilitate broad access to PrEP, particularly for populations at high risk of HIV acquisition.
• To provide a strategic framework for concluding the HIV epidemic in the U.S.

Main Methods:

• Analysis of current U.S. HIV prevention strategies.
• Development of a comprehensive financing model for PrEP.
• Design of an accessible and equitable PrEP delivery system.

Main Results:

• Identification of key barriers to PrEP utilization.
• A proposed system designed to overcome these barriers.
• A pathway to significantly increase PrEP uptake among vulnerable groups.

Conclusions:

• Implementing the proposed financing and delivery system is crucial for expanding PrEP access.
• Broad PrEP access is essential to achieving the goal of ending the HIV epidemic.
• Strategic interventions are needed to address the stagnation in HIV prevention efforts.